Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Research symbols : Mrna save search
Sail Biomedicines Provides Update on Research with Cystic Fibrosis Foundation and Pioneering Medicines
Published: 2024-01-05 (Crawled : 17:00) - biospace.com/
OMGA | $2.4 -0.83% -0.83% 400K
|
|
| O: 1.41%
H: 0.37%
C: -18.55%
SANA | $7.605 -1.62% -1.64% 3.4M
|
|
| O: 2.04%
H: 10.8%
C: 2.0%
MCRB | $0.5671 -2.93% -3.02% 3.7M
|
Health Technology
|
| O: 0.71%
H: 2.84%
C: -0.71%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.82%
H: 7.46%
C: 3.11%
FHTX | $5.335 -3.53% -3.66% 120K
|
Health Technology
|
| O: -1.79%
H: 7.65%
C: 2.55%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -2.47%
H: 0.66%
C: -2.18%
update fibrosis research
Moderna Highlights its Digital and AI Strategy and Progress at Second Digital Investor Event
Published: 2023-11-08 (Crawled : 12:30) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.01%
H: 0.03%
C: -3.14%
Global mRNA Vaccine Market Research Report 2023-2028: COVID-19 Success Opens New Avenues with with 444 Ongoing Clinical Studies Worldwide
Published: 2023-11-08 (Crawled : 03:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: 0.0%
VERV | News | $6.64 -0.3% -0.3% 1.1M
|
Professional, Scientific, and T...
|
| O: 0.37%
H: 0.64%
C: -10.76%
GSK | News | $39.75 1.22% 0.0% 1.6M
|
Health Technology
|
| O: 0.46%
H: 0.46%
C: -0.23%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.01%
H: 0.03%
C: -3.14%
CVAC | $2.44 0.0% 790K
|
Health Technology
|
| O: 0.91%
H: 1.08%
C: -1.44%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 0.13%
H: 0.08%
C: -2.81%
ARCT 4 | $25.995 -1.23% -1.25% 630K
|
Health Technology
|
| O: -0.36%
H: 0.79%
C: -0.61%
covid-19 success report vaccine mrna worldwide ongoing research global market
Global mRNA Vaccine and Therapeutics Market Research Report 2023: Market to Decrease by a CAGR of 34.01% to 2028
Published: 2023-05-17 (Crawled : 02:00) - prnewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.69%
H: 2.21%
C: 1.06%
BNTX | $86.82 0.75% 0.75% 1.6M
|
Health Technology
|
| O: 2.31%
H: 0.35%
C: -2.67%
report vaccine mrna research global therapeutics market
Moderna and IBM to Explore Quantum Computing and Generative AI for mRNA Science
Published: 2023-04-20 (Crawled : 12:00) - biospace.com/
IBM | News | $181.58 0.06% -0.32% 3M
|
Technology Services
|
| O: 3.03%
H: 0.64%
C: -2.91%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -0.99%
H: 2.14%
C: -0.18%
quantum mrna
Gandeeva and Moderna Enter into Cryo-EM Research Collaboration to Explore Protein Surface Structure at Atomic Resolution
Published: 2023-03-30 (Crawled : 11:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 0.94%
H: 0.7%
C: -1.84%
research protein collaboration
Moderna Granted FDA Breakthrough Therapy Designation for mRNA-1345, An Investigational Respiratory Syncytial Virus (RSV) Vaccine Candidate
Published: 2023-01-30 (Crawled : 13:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -1.12%
H: 0.19%
C: -3.4%
rna-1345 fda designation candidate vaccine respiratory virus granted therapy
Merck and Moderna Announce Exercise of Option by Merck for Joint Development and Commercialization of Investigational Personalized Cancer Vaccine
Published: 2022-10-12 (Crawled : 12:00) - biospace.com/
MRK | News | $125.78 0.44% 0.0% 8.4M
|
Health Technology
|
| O: 0.22%
H: 0.52%
C: -0.91%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 12.29%
H: 4.36%
C: -3.57%
vaccine commercialization cancer
Cellarity Announces Close of $121 Million Series C Financing
Published: 2022-10-04 (Crawled : 12:00) - biospace.com/
OMGA | $2.4 -0.83% -0.83% 400K
|
|
| O: 0.0%
H: 9.59%
C: 6.97%
SANA | $7.605 -1.62% -1.64% 3.4M
|
|
| O: 3.0%
H: 4.68%
C: 4.36%
MCRB | $0.5671 -2.93% -3.02% 3.7M
|
Health Technology
|
| O: 2.1%
H: 2.85%
C: 2.69%
RUBY | $0.057 -99.3% 760K
|
Health Technology
|
| O: 0.82%
H: 7.34%
C: 6.96%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.22%
H: 2.22%
C: 1.62%
FHTX | $5.335 -3.53% -3.66% 120K
|
Health Technology
|
| O: 3.15%
H: 7.96%
C: 3.06%
EVLO | $0.3165 -87.39% 710K
|
Health Technology
|
| O: 0.95%
H: 7.55%
C: 6.6%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: 2.26%
H: 2.33%
C: 1.48%
Moderna Announces New Supply Contract With The U.S. Government For An Initial 66 Million Doses Of A Moderna Bivalent Covid-19 Booster Vaccine
Published: 2022-07-29 (Crawled : 13:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.93%
H: 1.96%
C: 1.64%
covid-19 vaccine contract
EMA Committee for Medicinal Products for Human Use (CHMP) Recommends Use of the Moderna COVID-19 Booster in Adolescents (12-17 Years) in the European Union
Published: 2022-07-22 (Crawled : 13:20) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.7%
H: 0.0%
C: 0.0%
covid-19 ema
Moderna Announces First Participant Dosed in a Phase 1 Trial of its Nipah Virus mRNA Vaccine, mRNA-1215
Published: 2022-07-12 (Crawled : 12:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 0.33%
H: 0.0%
C: 0.0%
rna-1215 mrna virus trial phase 1
Moderna's Omicron-Containing Bivalent Booster Candidate, mRNA-1273.214, Demonstrates Significantly Higher Neutralizing Antibody Response Against Omicron Subvariants BA.4/5 Compared To Currently Authorized Booster
Published: 2022-07-11 (Crawled : 12:20) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
rna-1273 authorized antibody response
Moderna Announces Omicron-Containing Bivalent Booster Candidate mRNA-1273.214 Demonstrates Superior Antibody Response Against Omicron
Published: 2022-06-08 (Crawled : 12:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 5.95%
H: 3.57%
C: 0.72%
rna-1273 antibody response
Moderna Announces Advancements in mRNA Platform Science for Application Across Multiple Diseases at Science and Technology Day
Published: 2022-05-17 (Crawled : 12:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 2.31%
H: 0.0%
C: 0.0%
day application mrna technology platform disease
Moderna Announces Clinical Update on Bivalent COVID-19 Booster Platform
Published: 2022-04-19 (Crawled : 12:00) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -8.13%
H: 1.25%
C: 0.63%
covid-19 platform covid
Moderna Announces First Participants Dosed in Phase 1/2 Study with mRNA-1020 and mRNA-1030 Seasonal Influenza Vaccine Candidates
Published: 2022-04-11 (Crawled : 12:20) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -3.01%
H: 4.71%
C: 2.56%
rna-1020 vaccine influenza phase 1
Moderna Announces its COVID-19 Vaccine Phase 2/3 Study in Children 6 Months to Under 6 Years Has Successfully Met Its Primary Endpoint
Published: 2022-03-23 (Crawled : 12:30) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -1.1%
H: 0.59%
C: -3.21%
covid-19 children vaccine phase 2
UMass Chan Medical School announces research collaboration with Moderna to examine impact of Cytomegalovirus (CMV) in young children
Published: 2022-03-22 (Crawled : 14:30) - biospace.com/
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: 0.0%
H: 7.2%
C: 6.47%
research collaboration children
New Variants Throw the Spotlight on Booster Shots of COVID-19 Vaccines - According to New Research from StrategyR
Published: 2022-03-10 (Crawled : 15:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.52%
H: 1.67%
C: 1.67%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.85%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
NVAX | $3.99 2.57% 2.51% 2.9M
|
Health Technology
|
| O: -1.99%
H: 2.84%
C: 0.35%
MRNA S | $101.44 -0.55% -0.55% 2.6M
|
Health Technology
|
| O: -2.09%
H: 0.95%
C: 0.01%
covid-19 research covid vaccine
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.